Travere Therapeutics, Inc. (TVTX)
NASDAQ: TVTX · Real-Time Price · USD
19.80
-1.60 (-7.48%)
At close: Mar 3, 2025, 4:00 PM
19.79
-0.01 (-0.05%)
Pre-market: Mar 4, 2025, 5:08 AM EST
Travere Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Net Income | -321.55 | -111.4 | -278.48 | -180.09 | -169.43 | Upgrade
|
| Depreciation & Amortization | 43.56 | 38.53 | 20.72 | 12.75 | 24.58 | Upgrade
|
| Other Amortization | 1.73 | 1.72 | 1.62 | 11.24 | 10.48 | Upgrade
|
| Asset Writedown & Restructuring Costs | 65.21 | - | - | - | 97.13 | Upgrade
|
| Loss (Gain) From Sale of Investments | -4.54 | -7.46 | -0.7 | 2.01 | - | Upgrade
|
| Stock-Based Compensation | 36.91 | 44.25 | 38.14 | 29.57 | 23.61 | Upgrade
|
| Other Operating Activities | 11.68 | -265.52 | -43.02 | -32.48 | -3.07 | Upgrade
|
| Change in Accounts Receivable | -6 | -11.26 | -1.06 | 0.85 | 2.3 | Upgrade
|
| Change in Inventory | -3.77 | -39.42 | -1.21 | 0.12 | -5.07 | Upgrade
|
| Change in Accounts Payable | -17.56 | 24.76 | 2.06 | 2.47 | -6.04 | Upgrade
|
| Change in Unearned Revenue | -6.12 | -15.78 | -12.93 | 38.3 | - | Upgrade
|
| Change in Income Taxes | -0.04 | -0.04 | -0.37 | 17.1 | -15.75 | Upgrade
|
| Change in Other Net Operating Assets | -29.53 | 16.26 | 14.39 | 21.94 | -1.49 | Upgrade
|
| Operating Cash Flow | -237.48 | -280.02 | -186.29 | -14.79 | -42.74 | Upgrade
|
| Capital Expenditures | - | - | - | -5.1 | -6.77 | Upgrade
|
| Cash Acquisitions | - | - | - | - | -95.28 | Upgrade
|
| Sale (Purchase) of Intangibles | -101.21 | -41.59 | -28.37 | -19.05 | -17.8 | Upgrade
|
| Investment in Securities | 200.58 | -109.37 | -3.4 | -113.47 | 58.52 | Upgrade
|
| Other Investing Activities | -0.04 | 206.73 | -0.79 | - | - | Upgrade
|
| Investing Cash Flow | 99.33 | 55.78 | -32.55 | -137.62 | -61.33 | Upgrade
|
| Long-Term Debt Issued | - | - | 316.25 | - | - | Upgrade
|
| Long-Term Debt Repaid | - | - | -211.32 | - | - | Upgrade
|
| Net Debt Issued (Repaid) | - | - | 104.93 | - | - | Upgrade
|
| Issuance of Common Stock | 150.52 | 210.2 | 27.71 | 239.89 | 137.46 | Upgrade
|
| Other Financing Activities | -11.1 | 8.55 | -15.06 | -8.2 | -9.75 | Upgrade
|
| Financing Cash Flow | 139.42 | 218.75 | 117.57 | 231.68 | 127.71 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.91 | 1.98 | -2.79 | 1.71 | -1.31 | Upgrade
|
| Net Cash Flow | 0.36 | -3.51 | -104.07 | 80.98 | 22.34 | Upgrade
|
| Free Cash Flow | -237.48 | -280.02 | -186.29 | -19.89 | -49.51 | Upgrade
|
| Free Cash Flow Margin | -101.84% | -192.80% | -170.19% | -15.09% | -24.96% | Upgrade
|
| Free Cash Flow Per Share | -3.01 | -3.77 | -2.92 | -0.33 | -1.04 | Upgrade
|
| Cash Interest Paid | 8.84 | 8.84 | 10.16 | 7.33 | 6.9 | Upgrade
|
| Cash Income Tax Paid | 0.45 | 0.58 | 1 | -16.42 | -3.37 | Upgrade
|
| Levered Free Cash Flow | -228.53 | -178.11 | -163.35 | -60.79 | -46.34 | Upgrade
|
| Unlevered Free Cash Flow | -223.27 | -172.74 | -158.08 | -59.73 | -44.91 | Upgrade
|
| Change in Net Working Capital | 42.41 | -21.54 | -11.3 | -46.75 | 21.42 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.